AzTrials
AzTrials

Dentin HypersensitivityNCT04614727

Desensitizing Efficacy of Polymeric Nano Calcium Fluoride Containing Varnish

A study testing polymeric nano calcium fluoride containing varnish NANO SEAL in people with Dentin Hypersensitivity, run by Samar Saad.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the Desensitizing efficacy of polymeric nano calcium fluoride containing varnish and its implementation into clinical practice. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Dentin Hypersensitivity
What is being tested?
polymeric nano calcium fluoride containing varnish NANO SEAL
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
10 Feb 2021to 10 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients with good oral hygiene.
  • The age range of 18-65 years.
  • Patients from both gender.
  • Patients suffering from pain due to dentin hypersensitivity.
  • hypersensitive areas on facial surfaces of the teeth (incisors, cuspids, bicuspids, and first molars with exposed cervical dentine).
  • non carious cervical lesions: abrasion,erosion, abfraction, and recession with cervical dentin exposure

Who cannot join

  • Patient with bad oral hygiene.
  • Patients with constant use of analgesic, antihistaminic, anticonvulsive, sedative, tranquilizing, or anti-inflammatory medications 72 hours before treatment and pain assessment.
  • patients having received any desensitizing treatment during the last 3 months.
  • Patients with allergy of any materials will be used in the study . teeth with pulpitis.
  • teeth with periodontal disease installed.
  • teeth exhibiting mobility (grade 2 or 3).
  • carious lesions, fractured teeth, defective restorations or prosthesis.
  • Patients with orthodontics appliance.

About this study

Official title: Desensitizing Efficacy of Polymeric Nano Calcium Fluoride Containing Varnish Versus Casein Phosphopeptide Amorphous Calcium Phosphate Containing Fluoride Varnish: Randomized Clinical Trial

The aim of this study is to evaluate the Desensitizing efficacy of polymeric nano calcium fluoride containing varnish and its implementation into clinical practice.

Read the detailed description

Increasing the demand to find a desensitizing agent that should be biocompatible, easy to apply, painless, not changing the dental color, fast onset, and maintain a long-term effect gives a highlight to the patented formula of the polymeric nano calcium fluoride which newly introduced into the practice .

OliNano SEAL is an innovative "varnish-like" protector based on a patented silicone polymer with a true nano technology that provides an exceptional adhesion to enamel and dentin without prior etching for approximately 12 months (other available products max. 2-3 months).

It consists of four components Silicone polymer provides excellent adhesion to enamel and dentine, with transparent formula. NANO-fluoroapatite flows into enamel micro cracks \& seals it, penetrating into the dentinal tubules closing them eventually. As for the NANO-calcium fluoride it behaves as a fluoride reservoir, provides gradual and long-term fluoride release. The fourth component Amine fluoride (Olaflur) provides immediate fluoride ion release and accelerates natural remineralization.

Being tested
polymeric nano calcium fluoride containing varnish NANO SEAL
Keywords
Dentin sensitivity ,nano calcium fluoride, nano fluorapatite,Casein Phosphopeptide Amorphous Calcium Phosphate.
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • polymeric nano calcium fluoride containing varnish NANO SEALCombination product

    It consists of four components Silicone polymer provides excellent adhesion to enamel and dentine, with transparent formula. NANO-fluoroapatite flows into enamel micro cracks \& seals it, penetrating into the dentinal tubules closing them eventually. As for the NANO-calcium fluoride it behaves as a fluoride reservoir, provides gradual and long-term fluoride release. The fourth component Amine fluoride (Olaflur) provides immediate fluoride ion release and accelerates natural remineralization.

Study groups in NCT04614727
Study groupRoleWhat they receive
polymeric nano calcium fluoride containing varnish, NANO SEAL.ExperimentalNot described
Receives: Combination Product: polymeric nano calcium fluoride containing varnish NANO SEAL
Casein Phosphopeptide Amorphous Calcium Phosphate Containing Fluoride Varnish,MI varnishOtherCPP-ACP with 5%NaF
Receives: Combination Product: polymeric nano calcium fluoride containing varnish NANO SEAL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale VAS

    from 0-10 Pain absent: 0 Low pain:(1-3) Moderate pain: (4-6) Intense pain: (7-9) Extremely intense pain: 10.

    Measured: six months

  2. Schiff air score

    from 0-3 0: Tooth/subject did not respond to the air stimulus.

    1. Tooth/subject responded to the air stimulus but did not request discontinuation of the stimulus.
    2. Tooth/subject responded to the air stimulus and requested discontinuation or moved from the stimulus.
    3. Tooth/subject responded to the air stimulus, considered the stimulus to be painful, and requested discontinuation.

    Measured: six months

Secondary outcomes (1)
  1. Dentinal tubule occlusion

    Fully open, partially occluded and fully occluded dentinal tubules. (Percentage %)

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2020
  2. Study start10 Feb 2021 (estimated)
  3. Primary completion10 May 2021 (estimated)
  4. Study completion10 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04614727
Sponsor's protocol ID
Polymeric Nano Calcium Fluorid
Status last verified
Jan 2021
First submitted
23 Oct 2020
Last updated
26 Jan 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing polymeric nano calcium fluoride containing varnish NANO SEAL in people with Dentin Hypersensitivity, run by Samar Saad.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale VAS (time frame: six months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2021; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in